$14.20 0.55 (+4.03%)
11/6/2009 4:00 PM

Luminex Corp (LMNX)

CAPS Rating: 2 out of 5

The COmpany develops, manufactures and sells proprietary biological testing technologies with applications throughout the life sciences industry.

Current Price $14.20 Mkt Cap $589.1M
Open $13.51 P/E Ratio 147.20
Prev. Close $13.65 Div. (Yield) N/A (N/A)
Daily Range $13.41 - $14.31 Volume 1,256,173
52-Wk Range $13.56 - $24.92 Avg. Daily Vol. 269,000

LMNX News and Commentary

Caps

How do you think LMNX will perform vs the S&P 500?

Add Stock to Watchlist

All Members

87 Outperform
17 Underperform
 

All-Star Members

18 Outperform
7 Underperform
 

Wall Street

7 Outperform
0 Underperform
 

Top LMNX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

LeoGetz (36.99)
Submitted February 18, 2009

This stock looks like it has support around $18.50 plus the daily stochastics are at the very bottom. The risk to reward seems great on this one. Wish me luck.

Paramnesia1930 (97.08)
Submitted July 31, 2009

The 1929-1930 equity rally (coming out of The Great Depression) lasted 147 days and the market was up 46%. It has been the same amount of time since the March, 2009 low and we are up about the same percentage. It’s déjà vu (paramnesia), so… More

LMNX VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about LMNX.

Recs

0
Member Avatar JerryDreamer (< 20) Submitted: 8/17/2009 1:36:39 AM : Underperform Start Price: $15.81 LMNX Score: +19.08

When the overly optimistic FOMC says that household spending will be "constrained" by sluggish income growth, ongoing job losses, lower household wealth, and tight credit AND Shanghai stocks hit a seven-week low, then you know this bear market rally is finally over!

Recs

0
Member Avatar JPG101 (91.76) Submitted: 8/4/2009 1:28:38 AM : Outperform Start Price: $14.26 LMNX Score: +23.04

A small company with a market cap bellow 1 billion who sits at the center of an industry with its flow cytometry patents and technology. The list of their partners is truely impressive. This is a platform technology company who licences its tech to so many companies that it's difficult to keep track. Luminex is extremely well positioned to ride the wave of diagnostic upgrades that our medical system will eventually need to do. Many of the clinical tests we do are time consuming, labour intensive and slow. The current uncertainty in the health care market makes short term predictions about this and so many other diagnostic companies difficult but the significant funds unlocked as part of the stimulus package will certainly be a big accelerator for the research market that Luminex serves. The market seems to have partailly priced in the effect of the stimulus package for companies like Illumina, Life, Affymetrix and Luminex but might have overlooked the long term advantage that first movers can have in science diagnostics. Companies that are well positioned to sell their machines now might be 'locking in' for a significant amount of time. Their research platforms could become standards for a relatively long time. Research plateforms could also become stepping stones to the clinical market.

Recs

1
Member Avatar Paramnesia1930 (97.08) Submitted: 7/31/2009 7:06:25 PM : Underperform Start Price: $17.73 LMNX Score: +27.72

The 1929-1930 equity rally (coming out of The Great Depression) lasted 147 days and the market was up 46%. It has been the same amount of time since the March, 2009 low and we are up about the same percentage. It’s déjà vu (paramnesia), so prepare for a drop of about the same percentage (85%).

Leaderboard

Find the members with the highest scoring picks in LMNX.

Score Leader

IBDFool4U

IBDFool4U (94.63) Score: +104.71

The Score Leader is the member with the highest score across all their picks in LMNX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score Commentary
jimj43 < 20 1/14/2009 Underperform 3M $20.20 -29.70% +29.04% +58.75
Bucks1977 67.77 4/6/2009 10/1/2009 Underperform 3M $17.45 -18.62% +30.43% +49.05
DemonBzer 62.71 5/22/2007 Outperform 1Y $12.72 +11.64% -25.83% +37.46
XMFMYCROFT 94.13 9/10/2008 Underperform NS $26.39 -46.19% -10.76% +35.43
rpx < 20 11/28/2006 Outperform 3M $12.25 +15.92% -17.82% +33.74
msw331 43.91 12/8/2006 Outperform 1Y $12.69 +11.90% -19.41% +31.31
noskills 46.15 11/30/2006 Outperform 3M $12.72 +11.64% -19.34% +30.98
bhead123 < 20 1/12/2007 Outperform 1Y $12.81 +10.85% -19.99% +30.84
Paramnesia1930 97.08 8/3/2009 Underperform 3M $17.73 -19.91% +7.81% +27.72 1 Comment
kingp1221 58.61 5/1/2007 Outperform NS $13.70 +3.65% -23.59% +27.24

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackWedbush < 20 5/8/2009 Outperform NS $15.22 -6.70% +17.37% -24.07
TrackGlobalCrown < 20 11/7/2008 Outperform NS $20.44 -30.53% +19.94% -50.47
TrackGarpResearc 86.48 2/1/2008 Outperform NS $15.12 -6.08% -19.06% +12.97
TrackAvondale 91.47 1/16/2008 Outperform NS $17.13 -17.10% -18.96% +1.85
TrackCanaccord 84.17 9/11/2007 Outperform NS $14.85 -4.38% -23.25% +18.88
TrackTWeisel < 20 3/20/2007 Outperform NS $13.82 +2.75% -19.15% +21.90
TrackSoleil 83.54 12/11/2006 Outperform NS $13.48 +5.34% -19.60% +24.94

Featured Broker Partners